Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Oncology (Williston Park, N.Y.)
|
October 23, 2003
Phase II study of docetaxel and irinotecan in metastatic or recurrent esophageal cancer: a preliminary report
Ramaswamy Govindan, William Read, Joan Faust, et al.
Biomaterial Investigations in Dentistry
|
June 26, 2026
Evaluation of non-carious cervical restorations with different cavity configurations: a microscopy and OCT analysis
Ayla Macyelle de Oliveira Correia, Peter Hamilton Tomlins, Robert William Read, et al.
Clinical Imaging
|
April 28, 2019
The clincoradiologic spectrum of notochordal derived masses
Samia K Sayyid, Philip K Wong, William Read, et al.
Journal of Radiosurgery and SBRT
|
January 4, 2018
Clinical outcomes following image-guided stereotactic body radiation for pulmonary oligometastases
Daniel Kim, Mark M Fuster, Sameer K Nath, et al.
Journal of Radiosurgery and SBRT
|
January 4, 2018
Clinical outcomes following image-guided stereotactic body radiation for pulmonary oligometastases
Daniel Kim, Mark M Fuster, Sameer K Nath, et al.
Frontiers in Endocrinology
|
August 2, 2023
Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas
Eduardo J Medina, Youssef M Zohdy, Edoardo Porto, et al.
Annals of Surgical Oncology
|
July 17, 2021
Impact of Metastasectomy and Aggressive Local Therapy in Newly Diagnosed Metastatic Soft Tissue Sarcoma: An Analysis of the NCDB
Mustafa Abugideiri, James Janopaul-Naylor, Jeffrey Switchenko, et al.
JAMA
|
December 21, 2017
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial
Roger Stupp, Sophie Taillibert, Andrew Kanner, et al.
The Lancet. Oncology
|
June 28, 2017
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial
William D Tap, Zsuzsanna Papai, Brian A Van Tine, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Oncology (Williston Park, N.Y.)
|
October 23, 2003
Phase II study of docetaxel and irinotecan in metastatic or recurrent esophageal cancer: a preliminary report
Ramaswamy Govindan, William Read, Joan Faust, et al.
Biomaterial Investigations in Dentistry
|
June 26, 2026
Evaluation of non-carious cervical restorations with different cavity configurations: a microscopy and OCT analysis
Ayla Macyelle de Oliveira Correia, Peter Hamilton Tomlins, Robert William Read, et al.
Clinical Imaging
|
April 28, 2019
The clincoradiologic spectrum of notochordal derived masses
Samia K Sayyid, Philip K Wong, William Read, et al.
Journal of Radiosurgery and SBRT
|
January 4, 2018
Clinical outcomes following image-guided stereotactic body radiation for pulmonary oligometastases
Daniel Kim, Mark M Fuster, Sameer K Nath, et al.
Journal of Radiosurgery and SBRT
|
January 4, 2018
Clinical outcomes following image-guided stereotactic body radiation for pulmonary oligometastases
Daniel Kim, Mark M Fuster, Sameer K Nath, et al.
Frontiers in Endocrinology
|
August 2, 2023
Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas
Eduardo J Medina, Youssef M Zohdy, Edoardo Porto, et al.
Annals of Surgical Oncology
|
July 17, 2021
Impact of Metastasectomy and Aggressive Local Therapy in Newly Diagnosed Metastatic Soft Tissue Sarcoma: An Analysis of the NCDB
Mustafa Abugideiri, James Janopaul-Naylor, Jeffrey Switchenko, et al.
JAMA
|
December 21, 2017
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial
Roger Stupp, Sophie Taillibert, Andrew Kanner, et al.
The Lancet. Oncology
|
June 28, 2017
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial
William D Tap, Zsuzsanna Papai, Brian A Van Tine, et al.
Page
of 2